Clinical Trial Update: EVEREST II Pivotal Study High Risk Registry (HRR) [NA]

View source ↗

Summary

Pivotal study update for the EVEREST II High Risk Registry related to mitral valve repair/replacement research; status completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Valve Insufficiency
• Mitral Valve Regurgitation

Snippet

Sponsor: Abbott Medical Devices | Conditions: Mitral Valve Insufficiency, Mitral Valve Regurgitation | NA | Status: COMPLETED | Results posted: 2017-01-16